ATE309365T1 - Hiv-1 der gruppe 0, entsprechende fragmente dieses virus,sowie deren anwendungen - Google Patents

Hiv-1 der gruppe 0, entsprechende fragmente dieses virus,sowie deren anwendungen

Info

Publication number: ATE309365T1
Authority: AT; Austria
Prior art keywords: hiv; group; virus; applications; corresponding fragments
Prior art date: 1995-02-27

Application number

AT96904904T

Other languages

English (en)

Inventor

Francois Simon

Sentob Saragosti

Ibtissam Loussert-Ajaka

Thoai-Duong Ly

Marie-Laure Chaix-Baudier

Original Assignee

Inst Nat Sante Rech Med

Assist Publ Hopitaux De Paris

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-27

Filing date

1996-02-26

Publication date

2005-11-15

1996-02-26 Application filed by Inst Nat Sante Rech Med, Assist Publ Hopitaux De Paris filed Critical Inst Nat Sante Rech Med

2005-11-15 Application granted granted Critical

2005-11-15 Publication of ATE309365T1 publication Critical patent/ATE309365T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
General Engineering & Computer Science (AREA)
Peptides Or Proteins (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT96904904T 1995-02-27 1996-02-26 Hiv-1 der gruppe 0, entsprechende fragmente dieses virus,sowie deren anwendungen ATE309365T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9502236A FR2731013B1 (fr)	1995-02-27	1995-02-27	Vih-1 de groupe o, fragments desdits virus, ainsi que leurs applications
PCT/FR1996/000294 WO1996027013A1 (fr)	1995-02-27	1996-02-26	Vih-1 de groupe o, fragments desdits virus, ainsi que leurs applications

Publications (1)

Publication Number	Publication Date
ATE309365T1 true ATE309365T1 (de)	2005-11-15

Family

ID=9476523

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96904904T ATE309365T1 (de)	1995-02-27	1996-02-26	Hiv-1 der gruppe 0, entsprechende fragmente dieses virus,sowie deren anwendungen

Country Status (9)

Country	Link
US (2)	US6030769A (de)
EP (1)	EP0812359B1 (de)
JP (1)	JPH11501805A (de)
AT (1)	ATE309365T1 (de)
CA (1)	CA2214102C (de)
DE (1)	DE69635407T2 (de)
ES (1)	ES2256855T3 (de)
FR (1)	FR2731013B1 (de)
WO (1)	WO1996027013A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19505262C2 (de) *	1995-02-16	1998-06-18	Behring Diagnostics Gmbh	Retrovirus aus der HIV-Gruppe und dessen Verwendung
JP3560987B2 (ja) *	1997-04-09	2004-09-02	ビオ―ラド・パストゥール	グループｏｈｉｖ−１ウイルスによる感染検出用の生物学的アッセイに有用な合成ペプチド
FR2775287B1 (fr) *	1998-02-24	2000-11-24	Pasteur Sanofi Diagnostics	Peptides synthetiques consensus utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 du groupe o
FR2761993B1 (fr) *	1997-04-09	1999-05-21	Pasteur Sanofi Diagnostics	Peptides synthetiques utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 groupe 0
EP1003878A2 (de)	1997-07-18	2000-05-31	Innogenetics N.V.	Antigene von hiv-1 gruppe o und deren verwendungen
WO1999038887A1 (en) *	1998-01-28	1999-08-05	Universal Healthwatch, Inc.	Divergent hiv-1 peptides
EP0993615A1 (de) *	1998-03-04	2000-04-19	Universal Healthwatch, Inc.	Schnelltest für mikrobielle infektionen
WO1999062945A2 (en) *	1998-06-05	1999-12-09	Peptide Solutions, Inc.	Peptide antigens for detection of hiv, hcv and other microbial infections
CA2290217C (en) *	1998-11-30	2010-01-12	Ortho-Clinical Diagnostics, Inc.	Peptides for the detection of hiv-1 group o
NO311807B1 (no)	1999-03-04	2002-01-28	Bionor Immuno As	HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV
AU781934B2 (en) *	1999-07-09	2005-06-23	Gen-Probe Incorporated	Detection of HIV-1 by nucleic acid amplification
US6582920B2 (en)	2000-09-01	2003-06-24	Gen-Probe Incorporated	Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
FR2869045A1 (fr) *	2004-04-16	2005-10-21	Bioalliance Pharma Sa	Methode d'etude de la variabilite genetique et fonctionnelle du vih et kit pour sa mise en oeuvre
EP2742951B1 (de)	2004-09-14	2016-02-03	Argos Therapeutics, Inc.	Stammunabhängige Amplifikation von HIV Polynucleotiden
US10113206B2 (en) *	2010-02-24	2018-10-30	Grifols Therapeutics Inc.	Methods, compositions, and kits for determining human immunodeficiency virus (HIV)
WO2011119920A2 (en)	2010-03-25	2011-09-29	Oregon Health & Science University	Cmv glycoproteins and recombinant vectors
CA2832109C (en)	2011-06-10	2021-07-06	Oregon Health & Science University	Cmv glycoproteins and recombinant vectors
CA2789539A1 (en)	2011-09-12	2013-03-12	International Aids Vaccine Initiative	Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2679596B1 (de)	2012-06-27	2017-04-12	International Aids Vaccine Initiative	HIV-1 Env-proteinvariante
EP2848937A1 (de)	2013-09-05	2015-03-18	International Aids Vaccine Initiative	Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
EP2873423B1 (de)	2013-10-07	2017-05-31	International Aids Vaccine Initiative	Lösliche hiv-1-hüllglykoproteintrimere
EP3069730A3 (de)	2015-03-20	2017-03-15	International Aids Vaccine Initiative	Lösliche hiv-1-hüllglykoproteintrimere
US9931394B2 (en)	2015-03-23	2018-04-03	International Aids Vaccine Initiative	Soluble HIV-1 envelope glycoprotein trimers

1995
- 1995-02-27 FR FR9502236A patent/FR2731013B1/fr not_active Expired - Fee Related
1996
- 1996-02-26 WO PCT/FR1996/000294 patent/WO1996027013A1/fr active IP Right Grant
- 1996-02-26 ES ES96904904T patent/ES2256855T3/es not_active Expired - Lifetime
- 1996-02-26 EP EP96904904A patent/EP0812359B1/de not_active Expired - Lifetime
- 1996-02-26 DE DE69635407T patent/DE69635407T2/de not_active Expired - Lifetime
- 1996-02-26 CA CA2214102A patent/CA2214102C/fr not_active Expired - Fee Related
- 1996-02-26 US US08/894,699 patent/US6030769A/en not_active Expired - Lifetime
- 1996-02-26 JP JP8526057A patent/JPH11501805A/ja active Pending
- 1996-02-26 AT AT96904904T patent/ATE309365T1/de not_active IP Right Cessation
1999
- 1999-11-22 US US09/444,410 patent/US6270975B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2256855T3 (es)	2006-07-16
CA2214102C (fr)	2012-01-10
US6030769A (en)	2000-02-29
EP0812359B1 (de)	2005-11-09
EP0812359A1 (de)	1997-12-17
FR2731013B1 (fr)	1997-05-16
FR2731013A1 (fr)	1996-08-30
JPH11501805A (ja)	1999-02-16
CA2214102A1 (fr)	1996-09-06
DE69635407D1 (de)	2005-12-15
WO1996027013A1 (fr)	1996-09-06
DE69635407T2 (de)	2006-08-03
US6270975B1 (en)	2001-08-07

Publication	Publication Date	Title
ATE309365T1 (de)	2005-11-15	Hiv-1 der gruppe 0, entsprechende fragmente dieses virus,sowie deren anwendungen
ATE405679T1 (de)	2008-09-15	Synthetische humane neutralisierende monoklonale antikörper gegen hiv
TR199800327T1 (en)	1998-06-22	A�ilaminosalisilamidler.
NO970221L (no)	1997-03-18	Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus
DE60037450D1 (de)	2008-01-24	Funf-helix protein
NO951212D0 (no)	1995-03-29	Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus
BR9713388B1 (pt)	2009-01-13	processos de produÇço de vÍrus e de adenovÍrus recombinantes defectivos, e baculovÍrus recombinante.
DE69833160D1 (de)	2006-04-06	Amplifizierung und Detektion von HIV-1 und/oder HIV-2
DE69737683D1 (de)	2007-06-14	Antikörper gegen die ed-b domäne von fibronektin, ihre herstellung und verwendungen
DE69111440D1 (de)	1995-08-24	Methoden und zusammensetzungen zur impfung gegen hiv.
BR9909110A (pt)	2000-12-12	Usos de esmilagenina e anzurogenina d, compoisção farmacêutica tendo propriedades intensificadoras da função cognitiva, processo para intensificar a função cognitiva, e, composição para uso do mesmo
TR199801418T2 (xx)	1998-10-21	Rekombinant a�� vekt�rleri kar��m�.
HN1996000017A (es)	2000-03-24	Isotiazolonas
EA200000196A1 (ru)	2000-10-30	Универсальная плазма крови
ATE288900T1 (de)	2005-02-15	Substituierte benzoylcyclohexandione
DE3855134D1 (de)	1996-04-25	Monoklonale menschliche antikörper gegen hiv-i
BRPI9709524B8 (pt)	2021-05-25	processo para a produção de um anticorpo para células t que expressam cd4
PT1169057E (pt)	2005-03-31	Vacina anti-hiv-1 compreendendo o todo ou parte de uma proteina tat de vih-1
AU7299791A (en)	1991-10-03	Ultilization of enzymes
DK0946731T3 (da)	2009-06-22	Ikke-M, ikke O HIV-1 stammer, fragmenter og anvendelser
TR200000697T2 (tr)	2001-01-22	İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
FR2771751B1 (fr)	2000-05-26	Erythrovirus et ses applications
ES2088464T3 (es)	1996-08-16	Uso y administracion de enzimas.
PT633928E (pt)	2004-04-30	Microrganismos processo de preparacao e utilizacao
ES2115975T3 (es)	1998-07-01	Derivados de triariletileno utilizados terapeuticamente.

Legal Events

Date	Code	Title	Description
2006-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties